Comment on efficacy and safety of propranolol in the treatment of parotid hemangioma

Cutaneous and Ocular Toxicology

Volumn 30, Issue 4, 2011, Pages 333-334

  Zheng, Jia Wei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Hemangioma; Parotid gland; Propranolol

Indexed keywords

PROPRANOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

CHILD; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; HEMANGIOMA; HUMAN; INFANT; PAROTID GLAND; REVIEW; FEMALE; HEMANGIOENDOTHELIOMA; LIVER TUMOR; NOTE; PAROTID GLAND TUMOR; SECOND CANCER;

ADRENERGIC BETA-ANTAGONISTS; FEMALE; HEMANGIOENDOTHELIOMA; HEMANGIOMA; HUMANS; LIVER NEOPLASMS; NEOPLASMS, SECOND PRIMARY; PAROTID NEOPLASMS; PROPRANOLOL;

EID: 80455168321     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2011.584928     Document Type: Review

References (14)

1. Morais P, Magina S, Mateus M, Trindade E, Jesus JM, Azevedo F. Efficacy and safety of propranolol in the treatment of parotid hemangioma. Cutan Ocul Toxicol 2011.
2. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-2651. (Pubitemid 351831393)
3. Holmes WJ, Mishra A, Gorst C, Liew SH. Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas. J Plast Reconstr Aesthet Surg 2011;64:445-451.
4. Buckmiller LM, Munson PD, Dyamenahalli U, Dai Y, Richter GT. Propranolol for infantile hemangiomas: Early experience at a tertiary vascular anomalies center. Laryngoscope 2010;120:676-681.
5. Zvulunov A, McCuaig C, Frieden IJ, Mancini AJ, Puttgen KB, Dohil M et al. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: A multicenter retrospective study. Pediatr Dermatol 2011;28:94-98.
6. Naouri M, Schill T, Maruani A, Bross F, Lorette G, Rossler J. Successful treatment of ulcerated haemangioma with propranolol. J Eur Acad Dermatol Venereol 2010;24:1109-1112.
7. Missoi TG, Lueder GT, Gilbertson K, Bayliss SJ. Oral propranolol for treatment of periocular infantile hemangiomas. Arch Ophthalmol 2011.
8. Fridman G, Grieser E, Hill R, Khuddus N, Bersani T, Slonim C. Propranolol for the treatment of orbital infantile hemangiomas. Ophthal Plast Reconstr Surg 2011.
9. Guye E, Chollet-Rivier M, Schröder D, Sandu K, Hohlfeld J, de Buys Roessingh A. Propranolol treatment for subglottic haemangioma. Arch Dis Child Fetal Neonatal Ed 2011.
10. Peridis S, Pilgrim G, Athanasopoulos I, Parpounas K. A metaanalysis on the effectiveness of propranolol for the treatment of infantile airway haemangiomas. Int J Pediatr Otorhinolaryngol 2011;75:455-460.
11. Bagazgoitia L, Torrelo A, Gutiérrez JC, Hernández- Martín A, Luna P, Gutiérrez M et al. Propranolol for infantile hemangiomas. Pediatr Dermatol 2011;28:108-114.
12. Abbott J, Parulekar M, Shahidullah H, Taibjee S, Moss C. Diarrhea associated with propranolol treatment for hemangioma of infancy (HOI). Pediatr Dermatol 2010;27:558.
13. Holland KE, Frieden IJ, Frommelt PC, Mancini AJ, Wyatt D, Drolet BA. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol 2010;146:775-778.
14. Zheng JW. Invited commentary. J Plast Reconstr Aesthet Surg 2011;64:299-300.